- 4-Week # shares sold: 7,000
- 12-Week # shares sold: 7,000
- 24-Week # shares sold: 44,771
Trade-Ideas LLC identified BioMed Realty (BMR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Blackstone's $8 billion deal for the life-science-focused real estate company, BioMed, is the latest in a string of REIT acquisitions.
Cramer says Blackstone buying BioMed Realty Trust shows there is opportunity out there.